Topical Finasteride vs. Oral Finasteride: Full Comparison

Medically reviewed by [Reviewer Name, MD, Dermatology] | Last reviewed: August 2026 | Editorial policy | Topical finasteride hub

Note: Topical finasteride is not FDA-approved in the US. It is compounded and prescribed off-label. A valid US prescription is required.

The key question for men considering topical finasteride: is it as effective as oral, and does it actually have a better side effect profile? The short answer based on available clinical trial data: comparable efficacy, significantly less systemic DHT suppression, and a likely (but not yet conclusively proven) lower systemic side effect profile.

Full Comparison Table

Oral Finasteride 1 mgTopical Finasteride (compounded)
FDA approvalApproved for AGA (1997)Not approved (off-label, compounded)
Scalp DHT suppression~64%37% to 70% across doses (Caserini 2016)
Serum DHT suppression~70%34.5% (Piraccini 2022; oral arm 55.6%)
Hair efficacy vs. placeboEstablished (Kaufman 1998)Established (Piraccini 2022 Phase III)
Direct comparison to oralReferenceNumerically similar in Mazzarella 1997 (small RCT)
Sexual side effect risk~1-2% excess over placeboLower serum exposure = theoretically lower risk; not confirmed in large comparative RCTs
Evidence base (years)25+ years post-marketing~5-10 years of Phase II/III data
Route of administrationOnce-daily oral tabletOnce-daily scalp spray or solution
Typical cost/month$15, $35 (generic)$30, $70+ (compounded)
Prescription requiredYesYes
StandardizationFDA-regulated manufacturingVaries by compounding pharmacy
TeratogenicityPregnancy Category XApplies (systemic absorption occurs)

The Central Trade-Off

The core proposition of topical finasteride: same scalp DHT suppression, less systemic DHT suppression. If systemic DHT reduction is responsible for finasteride’s side effects (the prevailing hypothesis), topical should have fewer. The available trial data shows a favorable side effect profile at approved concentrations. But the evidence is from trials lasting 24 weeks or less, not the multi-year safety surveillance available for oral finasteride.

For men who have been on oral finasteride without side effects, there is no clinical reason to switch. For men who are concerned about systemic hormonal effects or who experienced side effects on oral finasteride, topical is a reasonable option to discuss with a dermatologist. Accepting that it is off-label and based on a smaller evidence base.

Frequently Asked Questions

Should I switch from oral to topical finasteride?

If you are taking oral finasteride without side effects and it is working, there is no clinical indication to switch. The added cost, off-label status, and smaller evidence base of topical finasteride do not offer advantages over well-tolerated oral therapy. If you experienced side effects on oral finasteride and want to continue treatment, topical finasteride is a reasonable discussion with your dermatologist.

Does topical finasteride still suppress systemic DHT?

Yes, to a smaller degree. Even topical application produces some systemic absorption; published trials show a 34.5% serum DHT reduction with topical finasteride in the largest Phase III trial (vs. 55.6% with oral). It is not zero systemic absorption, which is why the teratogenicity warning still applies, and why women who are or may become pregnant must not use it.

About this page: Reviewed by [Reviewer Name, MD, Dermatology]. Data from Piraccini 2022 Phase III, Caserini 2016, and Propecia PI. Last reviewed August 2026. Editorial policy.